Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis

Research output: Contribution to journal › Journal article › Research › peer-review

Standard

Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis. / Andersen, Ellen Sloth; Gerstoft, Jan; Weis, Nina Margrethe.

In: International Journal of Hematology, Vol. 92, No. 2, 01.09.2010, p. 378-80.

Research output: Contribution to journal › Journal article › Research › peer-review

Harvard

Andersen, ES, Gerstoft, J & Weis, NM 2010, 'Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis', International Journal of Hematology, vol. 92, no. 2, pp. 378-80. https://doi.org/10.1007/s12185-010-0648-z

APA

Andersen, E. S., Gerstoft, J., & Weis, N. M. (2010). Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis. International Journal of Hematology, 92(2), 378-80. https://doi.org/10.1007/s12185-010-0648-z

Vancouver

Andersen ES, Gerstoft J, Weis NM. Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis. International Journal of Hematology. 2010 Sep 1;92(2):378-80. https://doi.org/10.1007/s12185-010-0648-z

Author

Andersen, Ellen Sloth ; Gerstoft, Jan ; Weis, Nina Margrethe. / Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis. In: International Journal of Hematology. 2010 ; Vol. 92, No. 2. pp. 378-80.

Bibtex

@article{f579b16089874232ad20b48cd21782f7,
title = "Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis",
abstract = "We describe a case of reactivation of hepatitis D virus (HDV) in a patient treated with chemotherapy for a diffuse large B cell lymphoma despite lamivudine prophylaxis. This case suggests that previously cleared HDV should be considered when administering chemotherapy to patients with lymphoma.",
author = "Andersen, {Ellen Sloth} and Jan Gerstoft and Weis, {Nina Margrethe}",
year = "2010",
month = sep,
day = "1",
doi = "http://dx.doi.org/10.1007/s12185-010-0648-z",
language = "English",
volume = "92",
pages = "378--80",
journal = "International Journal of Hematology",
issn = "0925-5710",
publisher = "Springer",
number = "2",

}

RIS

TY - JOUR

T1 - Reactivation of hepatitis D virus after chemotherapy for diffuse large B cell lymphoma despite lamivudine prophylaxis

AU - Andersen, Ellen Sloth

AU - Gerstoft, Jan

AU - Weis, Nina Margrethe

PY - 2010/9/1

Y1 - 2010/9/1

N2 - We describe a case of reactivation of hepatitis D virus (HDV) in a patient treated with chemotherapy for a diffuse large B cell lymphoma despite lamivudine prophylaxis. This case suggests that previously cleared HDV should be considered when administering chemotherapy to patients with lymphoma.

AB - We describe a case of reactivation of hepatitis D virus (HDV) in a patient treated with chemotherapy for a diffuse large B cell lymphoma despite lamivudine prophylaxis. This case suggests that previously cleared HDV should be considered when administering chemotherapy to patients with lymphoma.

U2 - http://dx.doi.org/10.1007/s12185-010-0648-z

DO - http://dx.doi.org/10.1007/s12185-010-0648-z

M3 - Journal article

VL - 92

SP - 378

EP - 380

JO - International Journal of Hematology

JF - International Journal of Hematology

SN - 0925-5710

IS - 2

ER -

ID: 34052055